Molecular mechanisms of inflammation in the development of heart failure: A review

Cardiovascular diseases continue to be the main cause of hospital mortality and lead to great disability of the working population. Numerous clinical and experimental studies have shown that inflammation is the main factor causing the growth and progression of atherosclerosis. Despite significant pr...

Full description

Bibliographic Details
Main Authors: Yuri I. Buziashvili, Elmira U. Asymbekova, Elvina F. Tugeeva, Akmal Z. Rakhimov, Lusine S. Shakhnazaryan, Firdavsdzhon R. Akildzhonov
Format: Article
Language:Russian
Published: ZAO "Consilium Medicum" 2023-10-01
Series:Consilium Medicum
Subjects:
Online Access:https://consilium.orscience.ru/2075-1753/article/viewFile/626276/142168
_version_ 1797324164519952384
author Yuri I. Buziashvili
Elmira U. Asymbekova
Elvina F. Tugeeva
Akmal Z. Rakhimov
Lusine S. Shakhnazaryan
Firdavsdzhon R. Akildzhonov
author_facet Yuri I. Buziashvili
Elmira U. Asymbekova
Elvina F. Tugeeva
Akmal Z. Rakhimov
Lusine S. Shakhnazaryan
Firdavsdzhon R. Akildzhonov
author_sort Yuri I. Buziashvili
collection DOAJ
description Cardiovascular diseases continue to be the main cause of hospital mortality and lead to great disability of the working population. Numerous clinical and experimental studies have shown that inflammation is the main factor causing the growth and progression of atherosclerosis. Despite significant progress in basic therapy aimed at both preventing the development of heart failure (HF) and treating it, the prognosis in patients after their first hospitalization remains extremely unfavorable. HF is the leading cause of morbidity and mortality worldwide. Various stimuli at different stages of HF pathophysiology trigger a cascade of proinflammatory reactions with the release of interleukins, the formation of reactive oxygen species, mitochondrial DNA damage and the induction of autophagy. Based on the presented results from experimental and clinical studies, it can be expected that a better understanding of the molecular aspects in the pathophysiology of HF will open opportunities for the development of new therapeutic monoclonal antibodies.
first_indexed 2024-03-08T05:46:15Z
format Article
id doaj.art-fb7d857d42f644a383b26acc6ef5baf9
institution Directory Open Access Journal
issn 2075-1753
2542-2170
language Russian
last_indexed 2024-03-08T05:46:15Z
publishDate 2023-10-01
publisher ZAO "Consilium Medicum"
record_format Article
series Consilium Medicum
spelling doaj.art-fb7d857d42f644a383b26acc6ef5baf92024-02-05T11:33:58ZrusZAO "Consilium Medicum"Consilium Medicum2075-17532542-21702023-10-01251067968410.26442/20751753.2023.10.2024334752Molecular mechanisms of inflammation in the development of heart failure: A reviewYuri I. Buziashvili0https://orcid.org/0000-0001-7016-7541Elmira U. Asymbekova1https://orcid.org/0000-0002-5422-2069Elvina F. Tugeeva2https://orcid.org/0000-0003-1751-4924Akmal Z. Rakhimov3https://orcid.org/0000-0002-9370-9419Lusine S. Shakhnazaryan4https://orcid.org/0000-0001-7900-6728Firdavsdzhon R. Akildzhonov5https://orcid.org/0000-0002-1675-4216Bakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryCardiovascular diseases continue to be the main cause of hospital mortality and lead to great disability of the working population. Numerous clinical and experimental studies have shown that inflammation is the main factor causing the growth and progression of atherosclerosis. Despite significant progress in basic therapy aimed at both preventing the development of heart failure (HF) and treating it, the prognosis in patients after their first hospitalization remains extremely unfavorable. HF is the leading cause of morbidity and mortality worldwide. Various stimuli at different stages of HF pathophysiology trigger a cascade of proinflammatory reactions with the release of interleukins, the formation of reactive oxygen species, mitochondrial DNA damage and the induction of autophagy. Based on the presented results from experimental and clinical studies, it can be expected that a better understanding of the molecular aspects in the pathophysiology of HF will open opportunities for the development of new therapeutic monoclonal antibodies.https://consilium.orscience.ru/2075-1753/article/viewFile/626276/142168heart failureinflammationinterleukins
spellingShingle Yuri I. Buziashvili
Elmira U. Asymbekova
Elvina F. Tugeeva
Akmal Z. Rakhimov
Lusine S. Shakhnazaryan
Firdavsdzhon R. Akildzhonov
Molecular mechanisms of inflammation in the development of heart failure: A review
Consilium Medicum
heart failure
inflammation
interleukins
title Molecular mechanisms of inflammation in the development of heart failure: A review
title_full Molecular mechanisms of inflammation in the development of heart failure: A review
title_fullStr Molecular mechanisms of inflammation in the development of heart failure: A review
title_full_unstemmed Molecular mechanisms of inflammation in the development of heart failure: A review
title_short Molecular mechanisms of inflammation in the development of heart failure: A review
title_sort molecular mechanisms of inflammation in the development of heart failure a review
topic heart failure
inflammation
interleukins
url https://consilium.orscience.ru/2075-1753/article/viewFile/626276/142168
work_keys_str_mv AT yuriibuziashvili molecularmechanismsofinflammationinthedevelopmentofheartfailureareview
AT elmirauasymbekova molecularmechanismsofinflammationinthedevelopmentofheartfailureareview
AT elvinaftugeeva molecularmechanismsofinflammationinthedevelopmentofheartfailureareview
AT akmalzrakhimov molecularmechanismsofinflammationinthedevelopmentofheartfailureareview
AT lusinesshakhnazaryan molecularmechanismsofinflammationinthedevelopmentofheartfailureareview
AT firdavsdzhonrakildzhonov molecularmechanismsofinflammationinthedevelopmentofheartfailureareview